Marshall Financial Group LLC Has $2.04 Million Stake in Johnson & Johnson (NYSE:JNJ)

Marshall Financial Group LLC grew its stake in Johnson & Johnson (NYSE:JNJ) by 7.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,281 shares of the company’s stock after purchasing an additional 846 shares during the period. Marshall Financial Group LLC’s holdings in Johnson & Johnson were worth $2,037,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of JNJ. Hilltop Wealth Advisors LLC acquired a new stake in shares of Johnson & Johnson during the 1st quarter valued at about $842,000. Jacksonville Wealth Management LLC boosted its position in shares of Johnson & Johnson by 12.5% during the 1st quarter. Jacksonville Wealth Management LLC now owns 3,414 shares of the company’s stock valued at $566,000 after acquiring an additional 380 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new stake in shares of Johnson & Johnson during the 1st quarter valued at about $264,000. Schoolcraft Capital LLC acquired a new stake in shares of Johnson & Johnson during the 1st quarter valued at about $246,000. Finally, Lynch Asset Management Inc. boosted its position in shares of Johnson & Johnson by 2.8% during the 1st quarter. Lynch Asset Management Inc. now owns 11,050 shares of the company’s stock valued at $1,833,000 after acquiring an additional 300 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

JNJ has been the topic of several recent research reports. Leerink Partners lowered shares of Johnson & Johnson from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $169.00 to $153.00 in a research report on Tuesday, May 13th. Raymond James cut their price target on shares of Johnson & Johnson from $165.00 to $162.00 and set an “outperform” rating for the company in a report on Monday, April 14th. Royal Bank of Canada reissued an “outperform” rating and set a $181.00 price target on shares of Johnson & Johnson in a report on Thursday, June 5th. Leerink Partnrs downgraded shares of Johnson & Johnson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, May 13th. Finally, Guggenheim reissued a “neutral” rating on shares of Johnson & Johnson in a report on Wednesday, April 2nd. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $170.88.

Johnson & Johnson Trading Up 0.2%

JNJ opened at $156.90 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.11 and a quick ratio of 0.86. The company has a market cap of $377.52 billion, a price-to-earnings ratio of 23.59, a price-to-earnings-growth ratio of 2.56 and a beta of 0.42. The firm has a 50 day simple moving average of $153.84 and a 200 day simple moving average of $153.72. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $169.99.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, April 15th. The company reported $2.77 earnings per share for the quarter, topping analysts’ consensus estimates of $2.59 by $0.18. The business had revenue of $21.89 billion during the quarter, compared to the consensus estimate of $21.65 billion. Johnson & Johnson had a net margin of 18.20% and a return on equity of 34.24%. On average, sell-side analysts anticipate that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 10th. Investors of record on Tuesday, May 27th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, May 27th. This represents a $5.20 dividend on an annualized basis and a yield of 3.31%. This is a boost from Johnson & Johnson’s previous quarterly dividend of $1.24. Johnson & Johnson’s payout ratio is currently 57.84%.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.